Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma.
Fossella
F V
FV
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
Winn
R J
RJ
Holoye
P Y
PY
Raber
M N
MN
Holden
L
L
Belt
R
R
Allen
H
H
Hallinan
B
B
Harper
K
K
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013866:Thioguanine / Q000008:administration & dosage* / Q000009:adverse effects
D013866:Thioguanine